+91 95123 08383

Support 24/7

0Your Cart₹ 0.00

Cart (0)

No products in the cart.

DLD Voltage-Gated Potassium Channel (VGKC) Autoantibody RIA Elisa

₹ 0.00   ₹ 0.00

INTENDED USE 
The RSR VGKC autoantibody RIA kit is intended for use by professional persons only, for the quantitative determination of VGKC autoantibodies (VGKC Ab) in human serum. Serum VGKC Ab have been detected in peripheral nervous system disease specifically associated with the clinical spectrum of acquired neuromyotonia (NMT) and cramp-fasciculation syndrome (CFS), and disorders of the central nervous system, including Morvan syndrome, epilepsy and limbic encephalitis (LE). Detection and measurement of VGKC Ab are useful in the diagnosis and management of autoimmune Voltage-Gated Potassium Channelopathies and related neurological disorders. The kit is easy to use and provides a specific and sensitive assay for VGKC Ab.

Assay Type : Competitive
Format : 25 Determinations, 2 positive controls, 1 negative control
Pack Size : 96 wells
Storage : 2-8°C
Clinical Fields : Neurology, Immunology, Autoimmune Diseases
Sensitivity : Serum samples from 30 patients with suspected VGKC-pathies and related neurological disorders were assayed in the VGKC Ab RIA. 27 (90%) were positive for VGKC Ab.

Product Insert

In stock
SKU:RA115/25
Free Technical Support
Free Technical Support
Free Comprehensive Technical Support
Extensive Product Portfolio
Extensive Product Portfolio
Extensive range of critical & advanced research testing kits
Across Categories
Across Categories
Human, Veterinary, Food Safety, Research & Animal
Hotline Order:

Mon - Sat: 10AM - 06PM

(+91) 95123 08383

Become a Vendor?Register now

ASSAY PRINCIPLE 
In RSR’s VGKC Ab radioimmunoassay (RIA), VGKC Ab in patient sera and controls are allowed to interact with detergent solubilised VGKCs extracted from rabbit brain tissue and complexed with 125Ilabelled -dendrotoxin (known to react with Kv1.1, 1.2 and 1.6 subtypes of the VGKC). After incubation at 2-8 oC overnight, the resulting antigen-antibody complexes are immunoprecipitated by the addition of anti-human IgG. After a second incubation of 1½ hours, assay buffer is added and the samples centrifuged. Unbound 125I-labelled -dendrotoxin-VGKC complex is removed from the tubes by aspiration of the supernatant. The level of radioactivity remaining in the tube is proportional to the antibody level in the test sample.

STORAGE AND PREPARATION OF SERUM SAMPLES 
Sera to be analysed should be assayed soon after separation or stored, preferably in aliquots, at 2- 8 oC for up to 2 weeks, or at –20oC or below for longer periods. 15 L is sufficient for one assay. Repeated freeze thawing or increases in storage temperature must be avoided. Do not use lipaemic or haemolysed serum samples. Citrate, EDTA and heparin plasma may be used in the assay. When required, thaw test sera at room temperature and mix gently to ensure homogeneity. Dilute 1:10 using assay buffer (e.g. 15 µL serum plus 135 µL assay buffer). Centrifuge diluted serum prior to assay (preferably for 5 min at about 10,000rpm i.e. about 10,000g in a microfuge) to remove any particulate matter.

CLINICAL EVALUATION 
Clinical Specificity 
Sera from 100 individual healthy blood donors were assayed in the VGKC Ab RIA. 98 (98%) were identified as being negative for VGKC Ab. 
Clinical Sensitivity Serum samples from 30 patients with suspected Voltage-Gated Potassium Channelopathies and related neurological disorders were assayed in the VGKC Ab RIA. 27 (90%) were positive for VGKC Ab. 
Lower Detection Limit The negative control was assayed 20 times and the mean and standard deviation calculated. The lower detection limit at 2 standard deviations was 4.5 pmol/L.

Add your review

Your email address will not be published. Required fields are marked *

Please login to write review!

Upload photos

Looks like there are no reviews yet.

Related products